(Q38995052)

8 September 2017

title

Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice (English)

1 reference

8 September 2017

0 references

0 references

0 references

11

1 reference

8 September 2017

12

1 reference

8 September 2017

Irene Franco

3

0 references

Graziella Bruno

object named as

Graziella Bruno

8

0 references

author name string

Federica Barutta

1

1 reference

8 September 2017

Serena Grimaldi

2

1 reference

8 September 2017

Stefania Bellini

4

1 reference

8 September 2017

Roberto Gambino

5

1 reference

8 September 2017

Silvia Pinach

6

1 reference

8 September 2017

Alessandro Corbelli

7

1 reference

8 September 2017

Maria Pia Rastaldi

9

1 reference

8 September 2017

Teresa Aveta

10

1 reference

8 September 2017

Gabriella Gruden

13

1 reference

8 September 2017

language of work or name

English

0 references

publication date

14 May 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

86

1 reference

8 September 2017

issue

5

1 reference

8 September 2017

page(s)

979-990

1 reference

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Targeting the MCP-1/CCR2 System in diabetic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Cell biology of the glomerular podocyte

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Migratory fate and differentiation of blood monocyte subsets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Proteinuria with and without renal glomerular podocyte effacement.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Endocannabinoids in liver disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Modulating the endocannabinoid system in human health and disease--successes and failures

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Protective effects of PPARγ agonist in acute nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

PPARalpha activation upregulates nephrin expression in human embryonic kidney epithelial cells and podocytes by a dual mechanism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Mechanisms of diabetic nephropathy: role of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Podocytes in culture: past, present, and future

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Heat shock protein expression in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.165

7 January 2021

Identifiers

DOI

10.1038/KI.2014.165

1 reference

Dimensions Publication ID

8 September 2017

1004059403

0 references

1 reference